Schedule of Segment Reporting Information, by Segment |
Financial information relating to our reportable operating segments and reconciliations to the consolidated totals for the three and nine-month periods ended September 30, 2022 and 2021, were as follows (in thousands): | | | | | | | | | | | | | | | Three Months Ended | | Nine Months Ended | | | September 30, | | September 30, | | | 2022 | | 2021 | | 2022 | | 2021 | Net sales | | | | | | | | | | | | | Cardiovascular | | $ | 278,949 | | $ | 259,704 | | $ | 832,555 | | $ | 773,002 | Endoscopy | | | 8,226 | | | 7,317 | | | 25,011 | | | 23,257 | Total net sales | | | 287,175 | | | 267,021 | | | 857,566 | | | 796,259 | | | | | | | | | | | | | | Income from operations | | | | | | | | | | | | | Cardiovascular | | | 17,435 | | | 14,411 | | | 51,836 | | | 33,389 | Endoscopy | | | 1,222 | | | 1,520 | | | 5,310 | | | 5,631 | Total income from operations | | | 18,657 | | | 15,931 | | | 57,146 | | | 39,020 | | | | | | | | | | | | | | Total other expense — net | | | (1,055) | | | (1,754) | | | (4,672) | | | (5,284) | Income tax expense | | | 2,330 | | | 2,210 | | | 11,359 | | | 5,895 | | | | | | | | | | | | | | Net income | | $ | 15,272 | | $ | 11,967 | | $ | 41,115 | | $ | 27,841 |
|